Department of Medicine

Researchers must continually chase funding for their work. Kelly Dooley's prestigious award from the NIH is intended to help provide respite from that chase.

VUMC researchers found that peptides modified by highly reactive compounds called isolevuglandins activated T cells and promoted hypertension in mice. Their first-ever isolation of such peptides is a step toward potentially intervening in this pathologic process.

The award program “recognizes hospitals participating in the registry who have demonstrated sustained, top-level performance in quality of care and adherence to guideline recommendations."

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

Carolyn Audet, PhD, and Amanda Mixon, MD, MSPH, recently succeeded founding CCQIR director Sunil Kripalani, MD, MSc, professor of Medicine and Health Policy, and VUMC Vice President for Health System Sciences.

The research may lead to new treatments for diseases such as inflammatory bowel disease and mucositis, a severe complication of chemotherapy.

The new training program’s participants will focus their research efforts on substance use with an emphasis on vulnerable populations, such as people living with HIV.